Molina Healthcare Surprises with Quarterly Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy MOH?
Source: Fool
- Stock Surge: Molina Healthcare's stock surged 14.18% to $21.70 on Thursday, reflecting investor enthusiasm following its quarterly results, despite a 3% year-over-year revenue decline to $10.8 billion, indicating strong market confidence in its future potential.
- Profitability Decline: Molina's net income fell to $120 million ($2.35 per share) from $333 million a year ago, yet analysts had expected a lower adjusted EPS of $2.17, showcasing the company's resilience amid challenges.
- Impact of Membership Decline: The revenue drop was attributed to lower enrollment in the federal Medicaid program and the expiration of a Medicaid contract in Virginia, highlighting the company's reliance on the Medicaid market and the challenges it faces.
- Guidance Maintained: Management reaffirmed its full-year 2026 guidance, anticipating premium revenue of approximately $42 billion, a 2% decline from 2025, and adjusted net income of at least $5 per share, demonstrating stability and a positive outlook in a challenging environment.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MOH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MOH
Wall Street analysts forecast MOH stock price to rise
14 Analyst Rating
3 Buy
9 Hold
2 Sell
Hold
Current: 153.000
Low
155.00
Averages
180.85
High
250.00
Current: 153.000
Low
155.00
Averages
180.85
High
250.00
About MOH
Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which it offers managed healthcare services. Medicaid provides healthcare and long-term services and support to low-income Americans. Medicare is a federal program that provides eligible persons aged 65 and over, and some disabled persons, with a variety of hospital, medical insurance, and prescription drug benefits. The Marketplace insurance exchanges allow individuals and small groups to purchase federally subsidized health insurance. It arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, ancillary providers, and pharmacies.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Burry Optimistic on Molina's Medical Cost Performance
- Medical Cost Performance Beat: Molina Healthcare's Q1 medical care ratio reached 91.1%, significantly exceeding expectations and helping to stabilize investor concerns about rising healthcare costs, demonstrating the company's effectiveness in managing medical expenses.
- Earnings Outlook Improvement: Burry anticipates Molina could return to over $20 EPS, although the $25 target may take 2-3 years to achieve, indicating a growing confidence in the company's long-term profitability.
- Investor Sentiment Shift: Following Molina's earnings report, retail sentiment surged from 'bullish' to 'extremely bullish', with a 550% increase in message volume within 24 hours, reflecting optimism about the company's future prospects.
- Policy Tailwind Impact: Recent confirmation by U.S. regulators of a 2.48% increase in 2027 Medicare Advantage payment rates is expected to add over $13 billion in funding to private Medicare Advantage plans, further supporting Molina's growth potential.
See More
Molina Healthcare Surprises with Quarterly Results
- Stock Surge: Molina Healthcare's stock surged 14.18% to $21.70 on Thursday, reflecting investor enthusiasm following its quarterly results, despite a 3% year-over-year revenue decline to $10.8 billion, indicating strong market confidence in its future potential.
- Profitability Decline: Molina's net income fell to $120 million ($2.35 per share) from $333 million a year ago, yet analysts had expected a lower adjusted EPS of $2.17, showcasing the company's resilience amid challenges.
- Impact of Membership Decline: The revenue drop was attributed to lower enrollment in the federal Medicaid program and the expiration of a Medicaid contract in Virginia, highlighting the company's reliance on the Medicaid market and the challenges it faces.
- Guidance Maintained: Management reaffirmed its full-year 2026 guidance, anticipating premium revenue of approximately $42 billion, a 2% decline from 2025, and adjusted net income of at least $5 per share, demonstrating stability and a positive outlook in a challenging environment.
See More
Molina Healthcare Surprises with Quarterly Earnings Beat
- Earnings Surprise: Molina Healthcare reported a non-GAAP net income of $2.35 per share, exceeding analyst expectations of $2.17, despite a 3% year-over-year revenue decline to $10.8 billion, demonstrating the company's resilience in challenging times.
- Stock Surge: Following the earnings release, Molina's stock surged by 14%, indicating strong investor confidence in its financial performance, even though total revenue fell short of the consensus forecast of nearly $10.9 billion.
- Impact of Medicaid Membership Decline: The company attributed its revenue drop to lower enrollment in the federal Medicaid program and the expiration of a Medicaid contract in Virginia, highlighting the challenges faced in the competitive health insurance marketplace.
- Guidance Affirmation: Molina's management maintained its full-year 2026 guidance, projecting premium revenue of approximately $42 billion, a 2% decline from 2025, which reflects the company's confidence in navigating a turbulent market environment.
See More
Molina Healthcare Reports Q1 2026 Earnings and Reaffirms Guidance
- Financial Performance: Molina Healthcare reported approximately $10.2 billion in premium revenue and adjusted earnings per share of $2.35 for Q1 2026, demonstrating stability in revenue and profitability despite rising medical costs.
- 2026 Outlook: The company reaffirmed its full-year 2026 premium revenue guidance of approximately $42 billion and adjusted EPS of at least $5, indicating management's confidence in future performance, even as Medicaid membership attrition expectations increased from 2% to 6%.
- Strategic Shift: Molina plans to exit traditional MAPD products in 2027, focusing exclusively on dual-eligible members, a strategic adjustment aimed at optimizing resource allocation and enhancing profitability, reflecting the company's sensitivity to market changes.
- Market Risks: Management highlighted rising Medicaid attrition rates in states like California, Illinois, and New York, which could negatively impact future membership growth, emphasizing the uncertainty of market regulations and the complexities of policy implementation.
See More
Texas Instruments Forecasts Significant Earnings Increase
- Texas Instruments Earnings Outlook: Texas Instruments forecasts current-quarter earnings per share between $1.77 and $2.05, exceeding the consensus of $1.57, with revenue expected between $5 billion and $5.4 billion, significantly above the $4.86 billion anticipated by analysts, indicating strong performance and growth potential in the semiconductor market.
- American Airlines Performance: American Airlines shares rose over 4% after reporting first-quarter results that exceeded expectations, although the company cut its full-year earnings outlook due to rising fuel costs, reflecting the challenges and strategic responses in the high-cost airline industry.
- United Rentals Sales Forecast Increase: United Rentals shares jumped more than 23% after raising its full-year sales forecast to a range of $16.9 billion to $17.4 billion, demonstrating strong demand in the equipment rental market and a positive outlook heading into its busiest season.
- Molina Healthcare 2026 Forecast Confirmation: Molina Healthcare shares rose 10.3% after reaffirming its 2026 forecast, reporting first-quarter earnings of $2.35 per share on revenue of $10.8 billion, both surpassing analyst expectations, showcasing robust growth and profitability in the healthcare sector.
See More
Molina Healthcare Surges 15% After Q1 Earnings Beat Estimates
- Earnings Beat: Molina Healthcare reported Q1 adjusted EPS of $2.35, exceeding analyst expectations by $0.41, indicating strong profitability despite overall revenue of $10.79 billion missing consensus, reflecting intensified market competition.
- Revenue Decline Reasons: While the company affirmed its full-year premium revenue guidance of approximately $42 billion, Q1 premium revenue of $10.2 billion represented a 4% year-over-year decrease, primarily due to reduced Medicaid membership and the expiration of its Virginia Medicaid contract, impacting market share.
- Consolidated MCR: Molina reported a consolidated medical care ratio (MCR) of 91.1% for Q1, with a Medicaid MCR of 92.0%, indicating challenges in managing medical costs that could affect future profitability.
- Full-Year Guidance Affirmation: Despite revenue pressures, Molina reaffirmed its full-year guidance of at least $5.00 adjusted EPS, demonstrating confidence in future performance and aiming to restore market competitiveness through optimized product and pricing strategies.
See More
Burry Optimistic on Molina's Medical Cost Performance
- Medical Cost Performance Beat: Molina Healthcare's Q1 medical care ratio reached 91.1%, significantly exceeding expectations and helping to stabilize investor concerns about rising healthcare costs, demonstrating the company's effectiveness in managing medical expenses.
- Earnings Outlook Improvement: Burry anticipates Molina could return to over $20 EPS, although the $25 target may take 2-3 years to achieve, indicating a growing confidence in the company's long-term profitability.
- Investor Sentiment Shift: Following Molina's earnings report, retail sentiment surged from 'bullish' to 'extremely bullish', with a 550% increase in message volume within 24 hours, reflecting optimism about the company's future prospects.
- Policy Tailwind Impact: Recent confirmation by U.S. regulators of a 2.48% increase in 2027 Medicare Advantage payment rates is expected to add over $13 billion in funding to private Medicare Advantage plans, further supporting Molina's growth potential.
See More
Molina Healthcare Surprises with Quarterly Results
- Stock Surge: Molina Healthcare's stock surged 14.18% to $21.70 on Thursday, reflecting investor enthusiasm following its quarterly results, despite a 3% year-over-year revenue decline to $10.8 billion, indicating strong market confidence in its future potential.
- Profitability Decline: Molina's net income fell to $120 million ($2.35 per share) from $333 million a year ago, yet analysts had expected a lower adjusted EPS of $2.17, showcasing the company's resilience amid challenges.
- Impact of Membership Decline: The revenue drop was attributed to lower enrollment in the federal Medicaid program and the expiration of a Medicaid contract in Virginia, highlighting the company's reliance on the Medicaid market and the challenges it faces.
- Guidance Maintained: Management reaffirmed its full-year 2026 guidance, anticipating premium revenue of approximately $42 billion, a 2% decline from 2025, and adjusted net income of at least $5 per share, demonstrating stability and a positive outlook in a challenging environment.
See More
Molina Healthcare Surprises with Quarterly Earnings Beat
- Earnings Surprise: Molina Healthcare reported a non-GAAP net income of $2.35 per share, exceeding analyst expectations of $2.17, despite a 3% year-over-year revenue decline to $10.8 billion, demonstrating the company's resilience in challenging times.
- Stock Surge: Following the earnings release, Molina's stock surged by 14%, indicating strong investor confidence in its financial performance, even though total revenue fell short of the consensus forecast of nearly $10.9 billion.
- Impact of Medicaid Membership Decline: The company attributed its revenue drop to lower enrollment in the federal Medicaid program and the expiration of a Medicaid contract in Virginia, highlighting the challenges faced in the competitive health insurance marketplace.
- Guidance Affirmation: Molina's management maintained its full-year 2026 guidance, projecting premium revenue of approximately $42 billion, a 2% decline from 2025, which reflects the company's confidence in navigating a turbulent market environment.
See More
Molina Healthcare Reports Q1 2026 Earnings and Reaffirms Guidance
- Financial Performance: Molina Healthcare reported approximately $10.2 billion in premium revenue and adjusted earnings per share of $2.35 for Q1 2026, demonstrating stability in revenue and profitability despite rising medical costs.
- 2026 Outlook: The company reaffirmed its full-year 2026 premium revenue guidance of approximately $42 billion and adjusted EPS of at least $5, indicating management's confidence in future performance, even as Medicaid membership attrition expectations increased from 2% to 6%.
- Strategic Shift: Molina plans to exit traditional MAPD products in 2027, focusing exclusively on dual-eligible members, a strategic adjustment aimed at optimizing resource allocation and enhancing profitability, reflecting the company's sensitivity to market changes.
- Market Risks: Management highlighted rising Medicaid attrition rates in states like California, Illinois, and New York, which could negatively impact future membership growth, emphasizing the uncertainty of market regulations and the complexities of policy implementation.
See More
Texas Instruments Forecasts Significant Earnings Increase
- Texas Instruments Earnings Outlook: Texas Instruments forecasts current-quarter earnings per share between $1.77 and $2.05, exceeding the consensus of $1.57, with revenue expected between $5 billion and $5.4 billion, significantly above the $4.86 billion anticipated by analysts, indicating strong performance and growth potential in the semiconductor market.
- American Airlines Performance: American Airlines shares rose over 4% after reporting first-quarter results that exceeded expectations, although the company cut its full-year earnings outlook due to rising fuel costs, reflecting the challenges and strategic responses in the high-cost airline industry.
- United Rentals Sales Forecast Increase: United Rentals shares jumped more than 23% after raising its full-year sales forecast to a range of $16.9 billion to $17.4 billion, demonstrating strong demand in the equipment rental market and a positive outlook heading into its busiest season.
- Molina Healthcare 2026 Forecast Confirmation: Molina Healthcare shares rose 10.3% after reaffirming its 2026 forecast, reporting first-quarter earnings of $2.35 per share on revenue of $10.8 billion, both surpassing analyst expectations, showcasing robust growth and profitability in the healthcare sector.
See More
Molina Healthcare Surges 15% After Q1 Earnings Beat Estimates
- Earnings Beat: Molina Healthcare reported Q1 adjusted EPS of $2.35, exceeding analyst expectations by $0.41, indicating strong profitability despite overall revenue of $10.79 billion missing consensus, reflecting intensified market competition.
- Revenue Decline Reasons: While the company affirmed its full-year premium revenue guidance of approximately $42 billion, Q1 premium revenue of $10.2 billion represented a 4% year-over-year decrease, primarily due to reduced Medicaid membership and the expiration of its Virginia Medicaid contract, impacting market share.
- Consolidated MCR: Molina reported a consolidated medical care ratio (MCR) of 91.1% for Q1, with a Medicaid MCR of 92.0%, indicating challenges in managing medical costs that could affect future profitability.
- Full-Year Guidance Affirmation: Despite revenue pressures, Molina reaffirmed its full-year guidance of at least $5.00 adjusted EPS, demonstrating confidence in future performance and aiming to restore market competitiveness through optimized product and pricing strategies.
See More
